{"id":"W3135892107","doi":"10.1097/ieb.0b013e3181e47287","title":"BEVACIZUMAB VERSUS RANIBIZUMAB FOR AGE-RELATED MACULAR DEGENERATION: EARLY RESULTS OF A PROSPECTIVE DOUBLE-MASKED, RANDOMIZED CLINICAL TRIAL","year":2010,"lang":"en","type":"article","venue":"Evidence-Based Ophthalmology","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Ranibizumab; Macular degeneration; Reprint; Medicine; Bevacizumab; Randomized controlled trial; Ophthalmology; Clinical trial; Family medicine; Optometry; Surgery; Internal medicine; Chemotherapy","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004978936,0.001839904,0.004073466,0.0003748553,0.000569572,0.001625913,0.0009862708,0.002056129,0.004594339],"category_scores_gemma":[0.005958179,0.0008800115,0.002507373,0.0005935472,0.001143614,0.001296901,0.0004012488,0.002242377,0.0009422119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001128177,"about_ca_system_score_gemma":0.001252986,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001495264,"about_ca_topic_score_gemma":0.003245086,"domain_scores_codex":[0.9976608,0.001407785,0.0002059399,0.0003175252,0.0002060609,0.0002017861],"domain_scores_gemma":[0.9967245,0.001363136,0.0008937438,0.0003410125,0.0002349633,0.0004426666],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9903601,0.001443906,0.0003631838,0.0004503538,0.00121706,0.00002351714,0.00002814038,0.00006776545,0.0007657479,0.00004817725,0.0002654684,0.004966499],"study_design_scores_gemma":[0.9766049,0.02002672,0.001439602,0.0000469845,0.001197771,0.00001902202,0.00001314904,0.0001483922,0.0001275215,0.00007867201,0.0002836535,0.00001375575],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9669576,0.02231475,0.001144169,0.00100343,0.001124119,0.003678249,0.001253883,0.00009990906,0.002423831],"genre_scores_gemma":[0.9801567,0.007808902,0.002253721,0.001351818,0.001171403,0.003341269,0.001061187,0.00003053539,0.002824612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004978936,"threshold_uncertainty_score":0.02633148,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1224498431001592,"score_gpt":0.4232260892303289,"score_spread":0.3007762461301697,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}